DAX24.954 -0,1%Est506.039 -0,1%MSCI World4.343 -0,1%Top 10 Crypto8,5700 -2,3%Nas23.102 -0,6%Bitcoin56.401 -2,5%Euro1,1902 +0,1%Öl70,20 +1,6%Gold5.071 +0,9%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Siemens Energy ENER6Y SAP 716460 Rheinmetall 703000 BASF BASF11 NVIDIA 918422 Lufthansa 823212 Gerresheimer A0LD6E Microsoft 870747 Amazon 906866 Commerzbank CBK100 Deutsche Telekom 555750 DroneShield A2DMAA Allianz 840400 TUI TUAG50 Novo Nordisk A3EU6F
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX etwas tiefer -- Lufthansa: Streiks am Donnerstag -- Siemens Energy: Rekordaufträge -- Commerzbank hebt Ziele an -- Lyft, Moderna, Robinhood, VERBIO im Fokus
Top News
Analyse: Goldman Sachs Group Inc. vergibt Neutral an Deutsche Bank-Aktie Analyse: Goldman Sachs Group Inc. vergibt Neutral an Deutsche Bank-Aktie
Die zweite Welle der KI-Infrastruktur – Wo jetzt die künftigen Gewinner ansetzen! Die zweite Welle der KI-Infrastruktur – Wo jetzt die künftigen Gewinner ansetzen!
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Bone Therapeutics Aktie

Kaufen
Verkaufen
0,0021 EUR +0,0001 EUR +5,00 %
STU
0,0023 EUR ±0,0000 EUR ±0,00 %
EBR
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.1,50 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA14NHV

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINBE0974280126

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolBNZPF

Bone Therapeutics Aktien News

DatumMeistgelesen
GlobeNewswireBioSenic signs a new subscription agreement for a maximum of EUR 1.2M in convertible bonds
GlobeNewswireERRATUM: BioSenic on its way to find the necessary funds to perform its key clinical trial on chronic Graft-versus-Host Disease
GlobeNewswireBioSenic on its way to find the necessary funds to perform its key clinical trial on chronic Graft-versus-Host Disease
GlobeNewswireBioSenic provides third quarter 2023 Business Update
GlobeNewswireBioSenic to draw the final tranches of its present Global Tech Opportunities 15 convertible bonds program and secure runway end of January 2024
GlobeNewswireBioSenic S.A. : Transparency notifications received from François Rieger, Véronique Pomi, FA Dièse 3 SAS and Capital Grand Est SAS
GlobeNewswireBioSenic S.A. : Information on the total number of voting rights and shares
GlobeNewswireBioSenic performs further analysis of its phase 2 clinical trial data, leading to an optimal administration scheme for its next late-stage trial of arsenic trioxide in cGvHD
GlobeNewswireBioSenic publishes new evidence of beneficial effects of arsenic trioxide treatment supporting clinical trial for systemic sclerosis
GlobeNewswireBioSenic reaches agreement on binding term sheets with main creditors to restructure past financial debts
GlobeNewswireBioSenic reports half year 2023 results
GlobeNewswireBioSenic S.A. : Information on the total number of voting rights and shares
GlobeNewswireBioSenic receives a Chinese patent with broad claims, protecting the combined use of metal ions and arsenic salts to treat a wide range of serious diseases
GlobeNewswireBioSenic S.A. : Information on the total number of voting rights and shares
GlobeNewswireBioSenic provides further update on negotiations with its main creditors
GlobeNewswireBioSenic S.A. : Information on the total number of voting rights and shares
GlobeNewswireBioSenic provides financial update
GlobeNewswireBioSenic presents data on its new copper-arsenic trioxide combination for immunological disorders at the 25th International Conference on Redox Medicine
GlobeNewswireBioSenic puts Phase IIb ALLOB trial on hold
GlobeNewswireBioSenic SA : Information on the total number of voting rights and shares
GlobeNewswireBioSenic provides update regarding current license agreement with Phebra
GlobeNewswireBioSenic and Pluristyx sign term sheet for market availability of ALLOB mesenchymal cells
GlobeNewswireBioSenic provides First Quarter 2023 Business Update
GlobeNewswireBioSenic reacquires global IP rights and provides update on JTA-004 development
GlobeNewswireBioSenic to host Annual General Meeting on June 14 2023
GlobeNewswireBioSenic identifies key biomarkers for cGvHD and submits patent to EPO
GlobeNewswireBioSenic announces 2022 full year results
GlobeNewswireBioSenic receives key European patent from EPO, for further therapeutic development in cancer, infectious and immune diseases
GlobeNewswireBioSenic appoints Lieven Huysse, MD, as Chief Medical Officer
GlobeNewswireBioSenic provides Financial Update and Financial Calendar 2023
GlobeNewswireBioSenic publishes new data on the mechanism of action of arsenic trioxide (ATO)
GlobeNewswireBioSenic delivers a new post-hoc analysis of its Phase III JTA-004 trial on knee osteo-arthritis with positive action on the most severely affected patient population
GlobeNewswireBioSenic SA: Information on the total number of voting rights and shares
GlobeNewswireBioSenic optimizes statistical analysis for its ongoing ALLOB Phase IIb study for high-risk tibial fractures, requiring fewer patients and completes patient recruitment
GlobeNewswireBioSenic receives EUR 1 million from Pregene in accordance with terminated license agreement and expect new negotiations on common revisited grounds
GlobeNewswireBioSenic announces initiation of coverage by Portzamparc and Gilbert Dupont

Bone Therapeutics News

Bone Therapeutics News: auf dieser Seite finden Sie alle Bone Therapeutics News und Nachrichten zur Bone Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Bone Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Bone Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.